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Colorectal cancer (CRC) is highly prevalent in Western society with more than 14,000 
diagnoses and 4,000 deaths in Australia annually.  CRC is caused by both genetic and 
environmental risk factors, with a number of population studies linking high dietary iron and 
elevated body iron stores with increased CRC risk.  The iron overload disorder, hereditary 
haemochromatosis, is associated with increased risk of CRC, as are inflammatory bowel 
diseases including ulcerative colitis and Crohn’s disease.  A better understanding of the 
pathogenesis of CRC is required to develop improved medical therapies for individuals most 
at risk, such as those with hereditary haemochromatosis or inflammatory bowel diseases.  
Improved disease prevention and management is also important from a public health 
perspective, and will potentially decrease the incidence and mortality of this malignancy. 
In this study, a mouse model of inflammation-associated CRC was used to evaluate the 
effects of increasing dietary iron concentrations on tissue iron loading and colonic 
inflammation.  Two strains of mice (C57BL/6 and FVB/N) were evaluated to compare their 
responses to increased dietary iron levels. 
The results demonstrated that increased dietary iron increased colonic and liver iron 
deposition and colonic inflammation via an IL-6/STAT3 signalling pathway in a dose-
dependent manner.  Both colitis scores and plasma IL-6 levels were positively correlated with 
increased liver iron levels.  Both strains of mice showed similar trends in response to 
increased dietary iron concentration, though the magnitude of the responses varied between 
strains. 
In conclusion, the results from this study showed that increasing dietary iron concentrations 
exacerbate colonic inflammation, suggesting that high dietary iron consumption may be 
linked to an increased risk of CRC.
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